AbbVie expands Oxford R&D facility as part of £120 million-plus investment

More in Business

• Here’s why AMD’s stock is rising — and sending a confident message about the AI trade

  Strong quarterly financial results have eased market skepticism surrounding the endurance of the broader artificial intelligence sector. Advanced Micro Devices demonstrated tangible revenue gains from its AI initiatives despite a difficult operating environment for tech firms. The chipmaker's performance and subsequent optimistic financial forecast helped lift its shares during extended trading.

  1 min read
• 3M to take $5.8 billion hit under PFAS personal injury settlement

  The industrial manufacturing giant is confronting massive legal liabilities tied to chemical exposure claims across the country. This significant charge highlights the mounting corporate accountability surrounding historical environmental and health damages. The substantial financial obligation will notably impact the company's bottom line moving forward.

  1 min read
• Canva announces major job cuts after 'our hardest year yet'

  The Australian design platform is overhauling its global operations following its first growth slowdown in a decade and mounting expenses tied to artificial intelligence integration. Co-founder and CEO Melanie Perkins cited the recent operational difficulties as the primary driver behind the restructuring. The strategic shift comes as investors reduce their financial valuations of the business amid escalating technology costs.

  1 min read